A Study to Assess the PK of AL-794 Formulations in Healthy Subjects

NCT02877160 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: AL-794 suspension
DRUG: AL-794 tablet

Sponsor

Alios Biopharma Inc.